You have 9 free searches left this month | for more free features.

City

San Francisco (2)

Auckland (1)

Canberra (1)

Christchurch (1)

Costa Mesa (1)

Sacramento (1)

San Antonio (1)

West Bend (1)

Condition

Chronic Hepatitis C (1)

Hepatitis C, Chronic (1)

Pharmacokinetic Assessments in Healthy Volunteers (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Presidio Pharmaceuticals, Inc. (3)

Collaborator

Boehringer Ingelheim (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

ppi-668

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Hepatitis C Trial in San Francisco (PPI-668, BI 207127 Dose 1, BI 207127 Dose 2)

Completed

Chronic Hepatitis C

PPI-668
+5 more

San Francisco, California

Quest Clinical Research

Nov 24, 2015

Pharmacokinetic Assessments in Healthy Volunteers Trial in West Bend (PPI-668, Midazolam, Omeprazole)

Completed

Pharmacokinetic Assessments in Healthy Volunteers

PPI-668
+3 more

West Bend, Wisconsin

Spaulding Clinical Research

Mar 22, 2013

Hepatitis C, Chronic Trial in Australia, New Zealand, United States (PPI-668, Placebo)

Completed

Hepatitis C, Chronic

PPI-668
Placebo

Costa Mesa, California
+6 more

Nov 14, 2012